文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

血红素加氧酶-1调控非酒精性脂肪性肝病铁死亡作用机制的研究进展

[Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].

作者信息

Yuan X W, Nan Y M

机构信息

Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of Study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2024 Mar 20;32(3):262-267. doi: 10.3760/cma.j.cn501113-20240223-00089.


DOI:10.3760/cma.j.cn501113-20240223-00089
PMID:38584112
Abstract

Non-alcoholic fatty liver disease (NAFLD) has gradually become the most prevalent chronic liver disease in the world, but its pathogenesis has not been fully elucidated. Ferroptosis is a novel type of programmed cell death caused by iron-dependent lipid peroxidation. Heme oxygenase-1 is a recognized antioxidant enzyme and an important regulatory factor in ferroptosis that modulates ferroptosis through various pathways and, in turn, regulates NAFLD. This paper reviews the regulatory mechanism of heme oxygenase-1 on NAFLD in ferroptosis pathway, with a view to clarifying the occurrence and development mechanisms of NAFLD and providing new vision and targets for its prevention and treatment.

摘要

非酒精性脂肪性肝病(NAFLD)已逐渐成为全球最普遍的慢性肝病,但其发病机制尚未完全阐明。铁死亡是一种由铁依赖性脂质过氧化引起的新型程序性细胞死亡。血红素加氧酶-1是一种公认的抗氧化酶,也是铁死亡中的一个重要调节因子,它通过多种途径调节铁死亡,进而调控非酒精性脂肪性肝病。本文综述了血红素加氧酶-1在铁死亡途径中对非酒精性脂肪性肝病的调控机制,以期阐明非酒精性脂肪性肝病的发生发展机制,并为其防治提供新的思路和靶点。

相似文献

[1]
[Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].

Zhonghua Gan Zang Bing Za Zhi. 2024-3-20

[2]
Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.

Front Biosci (Landmark Ed). 2023-12-6

[3]
Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.

Biomedicines. 2021-11-10

[4]
Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.

J Nat Med. 2021-6

[5]
Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.

Lipids Health Dis. 2023-7-8

[6]
Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?

Liver Int. 2022-7

[7]
An overview of ferroptosis in non-alcoholic fatty liver disease.

Biomed Pharmacother. 2022-9

[8]
Heme oxygenase-1 modulates ferroptosis by fine-tuning levels of intracellular iron and reactive oxygen species of macrophages in response to infection.

Front Cell Infect Microbiol. 2022

[9]
Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding.

Front Endocrinol (Lausanne). 2024

[10]
Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.

Toxicology. 2020-12-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索